NCT07324096 2026-03-19
AI-PACED
Mayo Clinic
Phase NA Not yet recruiting
Clinical Trials
12 trialsNCT07199764 2026-03-06
IGNITE
University of Pennsylvania
Phase 2 Recruiting
NCT05634720 2026-01-26
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Duke University
Phase 4 Active not recruiting
NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
NCT03851237 2025-12-23
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Phase 1 Completed
NCT05289830 2025-12-10
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT04975217 2025-11-21
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06600906 2025-11-12
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
University of California, San Francisco
Recruiting
NCT05209074 2025-09-05
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
Case Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT03592888 2025-06-29
DC Vaccine in Pancreatic Cancer
University of Pennsylvania
Phase 1 Completed
NCT03374852 2025-04-29
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Thomas Jefferson University
Phase 2 Withdrawn
NCT05365893 2025-04-16
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting